Meet ISPOR Board Of Directors
Zeba M. Khan, RPh, PhD
TREASURER (2013-2020): Zeba M. Khan, RPh, PhD

Dr. Zeba Khan is Vice President of Corporate Responsibility for Celgene Corporation, a multinational biopharmaceutical company focusing on the discovery, development, and commercialization of treatments for cancer and severe, immune, inflammatory conditions. Zeba also has direct responsibility for managing Celgene’s global health capacity building and access initiatives. Zeba serves as the Corporate Affairs lead for the Inflammation & Immunology Franchise and is a member of the Corporate Affairs Leadership Team.

Zeba joined Celgene in 2008 as Vice President, Pricing and Market Access, establishing the Global Pricing and Market Access function and leading the development and implementation of pricing, health economics, outcomes research, and market access strategies. In 2012, Zeba joined Corporate Affairs as Vice President, Strategic Market Access & Policy, establishing the public policy function that has been integral in shaping market access policy issues and enhancing public policy advocacy for Celgene.

Prior to joining Celgene Corporation, Zeba held various leadership positions at Novartis including Global Head of Pricing and Health Economics, CVM in Basel, Switzerland and Executive Director, Head of Pricing Strategy and Policy in East Hanover, New Jersey. Before joining Novartis, she held various leadership roles in Healthcare Management/Managed Markets and Health Economics and Outcomes Research at GlaxoSmithKline in Research Triangle Park, North Carolina. Prior to joining the biopharmaceutical industry, Zeba was a clinical pharmacist at the University of Utah Health Sciences Center in Salt Lake City, Utah.

Zeba serves on the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors and is currently the ISPOR Treasurer. She has been an active member of ISPOR since 1996 serving on numerous committees including Chair of the ISPOR Short Course Committee, ISPOR Institutional Council, and the Student Network Faculty Advisor. Zeba serves on the Board of Directors of the New Jersey Crossroads Chapter of the American Red Cross and is currently the Board Chair. Zeba also serves on the University of Washington School of Pharmacy, Pharmaceutical Outcomes Research & Policy Corporate Advisory Board and on the Rutgers Ernest Mario School of Pharmacy Health Outcomes, Policy and Economics Corporate Advisory Board. Zeba is also an adjunct assistant professor at the Ernest Mario School of Pharmacy at Rutgers University. She is active with several other professional and non-profit organizations. 

Zeba earned her pharmacy degree from the University of Utah and her M.S. and Ph.D. in Pharmacoeconomics/Health Economics and Outcomes Research from The University of Texas at Austin. Over her 25-year career, she has authored/co-authored over 90 publications/presentations in the health services research field.

ISPOR VISION Statement by Zeba M. Khan, RPh, PhD

I have been an active member of ISPOR since its beginnings and have contributed to the great progress that the organization has made both scientifically and financially. As Treasurer, my goal is to continue this tradition of growth through financially sound decisions and create a solid organizational infrastructure for its future. ISPOR has realized strong financial performance in every year since its inception and I would like to ensure that continued strong performance as its Treasurer.

ISPOR has rapidly progressed from essentially a small business to a professional association. ISPOR is expanding and reaching multiple stakeholders globally and with those come increased financial responsibility. With proper financial stability, growth, and investment, ISPOR will continue to grow as an association. We are just now beginning to put sound financial investment strategies and infrastructure in place and, at this phase of development, continuity is crucial; I will provide that continuity and ensure we succeed with these strategies to advance ISPOR. We should strive to increase and diversify investments to continue our revenue growth. We should also strategically invest to meet the needs of the organization and to ensure its financial integrity and sustainability. It is an honor to serve as ISPOR Treasurer for another term and ensure that sound financial strategies are applied to secure the future of ISPOR.


Board of Directors Main Page